X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com//news-release/2023/10/12/2759269/0/en/RespireRx-Pharmaceuticals-Inc-s-Subsidiary-ResolutionRx-Ltd-Enters-into-Master-Services-Agreement-for-Dronabinol-Manufacturing-and-Related-Services.html
https://www.pharmacompass.com/pdf/news/enforcement-report-for-week-of-june-28-2023-96236.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/harvard-drug-group-llc-issues-voluntary-nationwide-recall-dronabinol-capsules-usp-25-mg-and
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/harvard-drug-group-llc-issues-voluntary-nationwide-recall-dronabinol-capsules-usp-25-mg-and
https://health.economictimes.indiatimes.com/news/pharma/stigma-in-drug-research-holding-back-new-therapies/94760467
https://www.globenewswire.com/news-release/2022/08/08/2493798/0/en/RespireRx-Pharmaceuticals-Inc-Announces-that-Sleep-Review-has-discussed-the-RespireRx-Dronabinol-Obstructive-Sleep-Apnea-OSA-Program-in-its-June-13-2022-Edition.html
https://www.newswire.ca/news-releases/empowerpharm-becomes-the-first-canadian-pharmaceutical-company-with-a-certified-gmp-facility-fully-dedicated-to-manufacture-cbd-tablets-and-capsules-854702673.html#:~:text=Health%20Canada%20has%20certified%20the,in%20more%20than%20four%20decades.
https://medicalxpress.com/news/2020-05-legal-cannabis-hemp-oil-effectively.html
https://www.prnewswire.com/news-releases/new-player-cantourage-challenges-canopy-growth-on-dronabinol-cannabis-monopoly-in-europe-301047598.html
https://endpts.com/can-cbd-temper-parkinsons-related-psychosis-uk-researchers-will-look-for-answers-in-phase-ii-study/
https://www.reuters.com/article/us-health-vaping-cdc-factbox/factbox-vaping-related-illnesses-cause-16-u-s-deaths-oregon-reports-second-fatality-idUSKBN1WH1SZ
https://www.biospace.com/article/releases/intec-pharma-announces-results-from-earlier-phase-2-clinical-trial-of-accordion-pill-carbidopa-levodopa-in-advanced-parkinson-s-disease-patients-published-in-parkinsonism-and-related-disorders/
https://www.reuters.com/article/us-canada-cannabis/health-canada-to-allow-some-edible-cannabis-products-starting-mid-december-idUSKCN1TF2B4
https://www.reuters.com/article/us-gw-pharma-dea/gw-pharma-cannabis-drug-set-to-hit-market-following-dea-nod-idUSKCN1M71WI?feedType=RSS&feedName=healthNews
https://globenewswire.com/news-release/2018/07/05/1533643/0/en/Zynerba-Pharmaceuticals-Announces-Top-Line-Results-from-ZYN001-THC-Prodrug-Patch-Phase-1-Study.html
https://endpts.com/thc-therapy-tanks-in-phi-sending-zynerbas-stock-tumbling-yet-again/
https://www.prnewswire.com/news-releases/therapix-biosciences-announces-enrollment-of-the-first-patient-for-clinical-trial-at-assuta-medical-center-for-treating-obstructive-sleep-apnea-using-cannabinoid-based-drug-300660370.html
https://www.prnewswire.com/news-releases/lannett-receives-fda-approval-for-dronabinol-capsules-300651594.html
https://www.prnewswire.com/news-releases/therapix-biosciences-announces-fda-clearance-of-investigational-new-drug-ind-for-phase-iia-clinical-trial-of-thx-110-in-the-treatment-of-chronic-low-back-pain-300616646.html
https://www.prnewswire.com/news-releases/intec-pharma-partners-with-lts-for-manufacture-of-accordion-pill-carbidopalevodopa-for-treatment-of-parkinsons-disease-676589423.html
https://www.wsj.com/articles/opioid-maker-insys-still-has-fans-on-wall-street-1520286053
https://www.in-pharmatechnologist.com/Article/2018/01/04/Intec-gets-Canadian-patent-for-Accordion-Pill-controlled-release-tech
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-syndros-dronabinol-oral-solution-1498628768.pdf
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2017/04/is-it-scheduling-or-rescheduling-dea-issues-interim-rule-on-oral-solutions-of-dronabinol-.html
http://www.dddmag.com/article/2017/02/gw-pharmas-cannabis-derived-drug-shows-promise-brain-cancer-study
http://www.in-pharmatechnologist.com/Regulatory-Safety/Cannabis-grower-gains-EMA-GMP-status-for-Dutch-plants
http://www.in-pharmatechnologist.com/Ingredients/Chewing-on-a-cannabis-based-gum-to-treat-IBS
http://www.biospace.com/News/an-abandoned-pfizer-drug-turns-people-into-zombies/442152/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://www.forbes.com/sites/debraborchardt/2016/11/03/insys-therapeutics-pops-on-earnings-beat-but-revenues-plunge/#38d438087253
http://www.pharma-excipients.ch/2016/07/19/gelatin-hydroxypropyl-methylcellulose-matrices-polymer-interactions-approach-for-oral-disintegrating-films/
http://www.pharmatimes.com/Article/15-03-31/GW_tests_cannabinoid_drug_in_PhIII_epilepsy_trial.aspx
http://www.taurigasciences.com/news/press-releases/2015/02/tauriga-sciences-inc-completes-manufacturing-of-cannacaviar-cbd-soft-gels/
Market Place
Share 
